- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03796585
Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies
Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies: A Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The purpose of this study is to identify barriers to utilization of immunization registries within a pharmacy context and tailor the information learned about barriers into a novel immunization registry training program with strategies specific to individual subsets of pharmacies, independent pharmacies in rural areas. Doing so will help achieve the long-term goal which is to increase the use of immunization registries in community pharmacies in Alabama.
The specific aims are to
- identify barriers and best practices of immunization registry implementation,
- use a participatory design approach to develop an immunization registry training program, and
- disseminate and assess the impact of the immunization registry training program among community pharmacies' registry participation rates.
The impact of the training program on registry participation rates will be assessed using a randomized controlled trial design comparing Alabama community pharmacies' registry data as well as intention to participate.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Auburn, Alabama, Forenede Stater, 36849
- Auburn University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- not currently enrolled in ImmPRINT
- currently provide at least one type of vaccination in addition to influenza
- independently owned
- agree to provide requested data for assessment
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Intervention
Pharmacists assigned to this group will receive an immunization registry training program and informational flyer.
|
Education highlighting practical strategies to improve pharmacies' willingness to adopt the immunization registry and improve their ability to integrate the immunization registry into their pharmacy workflow.
Informational flyer with ImmPRINT contact information
|
Aktiv komparator: Control
Pharmacists assigned to this group will receive an informational flyer.
They will not receive training.
|
Informational flyer with ImmPRINT contact information
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Number of pharmacies enrolled in the Alabama Immunization Registry
Tidsramme: 3 months
|
The change in the number of participant pharmacies enrolled in the Alabama immunization registry from baseline to 3 months.
|
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Level of Immunization Registry Participation
Tidsramme: 3 months
|
Proportion of self-reported doses administered that are verified in the immunization registry.
|
3 months
|
Change in awareness
Tidsramme: 1 month and 3 months
|
The change in participant awareness of immunization registries from baseline to 3 months assessed by online questionnaire at baseline, one month, and three months.
Awareness will be measured using three true or false items.
Each item will be scored, 0 for an incorrect answer and 1 for a correct answer.
Awareness index is the sum of the 3 items and could range from 0-3 with higher values representing greater awareness.
|
1 month and 3 months
|
Change in knowledge
Tidsramme: 1 month and 3 months
|
The extent to which participant is familiar with and understands immunization registries will be assessed via online questionnaire at baseline, one month, and three months.
Eight true or false and multiple answer items will be used to measure knowledge.
Each item will be scored, 0 for an incorrect answer and 1 for a correct answer.
Knowledge is the sum of the 8 items and could range from 0-8 with higher values representing greater knowledge.
|
1 month and 3 months
|
Change in attitudes
Tidsramme: 1 month and 3 months
|
Participant's perceptions toward attributes of the immunization registry assessed via online questionnaire at baseline, one month, and three months.
A scale including 25 Likert-type items will be used to measure attitudes.
Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree.
Mean scores will be calculated for the 25 items in the scale so that attitudes score range from 0 to 6 with higher values indicating greater positive attitudes.
|
1 month and 3 months
|
Change in intention to enroll in immunization registry
Tidsramme: 1 month and 3 months
|
Participant's likelihood to enroll their pharmacy in the immunization registry assessed via online questionnaire at baseline and one month.
A scale including 3 Likert-type items will be used to measure intention.
Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree.
Mean scores will be calculated for the three items in the scale so that intention score ranges from 0 to 6 with higher values indicating greater intention.
|
1 month and 3 months
|
Change in Implementation Factors
Tidsramme: 3 months
|
Implementation factors informed by the Consolidated Framework for Implementation Research (CFIR) including innovation characteristics, characteristics of individuals, inner setting, outer setting, and process will be assessed via online questionnaire at baseline and three months.
A scale including 42 Likert-type items will be used to measure Implementation Factors.
Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree.
Mean scores will be calculated so that the implementation factors score ranges from 0 to 6 with higher values indicating greater positive influence of CFIR implementation factors.
|
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 1R36HS026093-01A1 (U.S.A. AHRQ bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Immunization Registry Training
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Myriad Genetics, Inc.Afsluttet
-
The Hospital for Sick ChildrenAktiv, ikke rekrutterendeSjældne histiocytiske lidelser (RHD'er) | Juvenil Xanthogranuloma (JXG) | Reticulohistiocytom (Epithelioid Histiocytom) | Xanthoma disseminatum (XD) | Multicentrisk retikulohistiocytose (MRH) | Systemisk juvenil xanthogranulom | Erdheim-Chesters sygdom (ECD) | Multisystem Rosai-Dorfmans sygdom (RDD)Canada, Forenede Stater, Polen, Argentina, Østrig, Tjekkiet, Tyskland, Italien, Den Russiske Føderation, Spanien
-
University of UlmRekrutteringBCR-ABL1-negative myeloide neoplasmerTyskland
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsAfsluttetGastrointestinale stromale tumorerForenede Stater
-
M.D. Anderson Cancer CenterAfsluttetIkke-småcellet lungekræftForenede Stater
-
M.D. Anderson Cancer CenterRekruttering
-
RefleXion MedicalRekrutteringKræft | Kræft, mave-tarm | Kræft centralnervesystemet | Kræft thorax | Kræft gynækologisk | Kræft, Genito-Urin | Kræft lymfe | Kræft hoved og halsForenede Stater
-
Biotronik, Inc.AfsluttetPatienter indiceret for en ICDForenede Stater
-
Biotronik, Inc.AfsluttetKongestiv hjertesvigtForenede Stater
-
Aventyn, Inc.Karolinska Institutet; Intel Corporation; Abrazo Health Network; ASU College...RekrutteringCovid19Forenede Stater, Indien, Sverige